Zaleplon clinical trials
Also written Sonata.
How each study uses zaleplon is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- 13 Aug 1999 · SONATA · NDA 020859 (FDA, Drugs@FDA)
- European Union
- 12 Mar 1999 · Sonata · EMEA/H/C/000227 (EMA; now withdrawn)
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
9 studies that test it; most in 2004 (4)
| Year | Studies |
|---|---|
| 2004 | 4 |
| 2008 | 1 |
| 2010 | 2 |
| 2014 | 1 |
| 2015 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 6 · Other 3
Teva Pharmaceuticals USA (2) · Roxane Laboratories (2) · University of Pennsylvania (1) · Alexza Pharmaceuticals, Inc. (1) · St. Luke's Hospital, Chesterfield, Missouri (1) · Somnus Therapeutics, Inc. (1) · Hannover Medical School (1)
Often tested with
Tested in the same studies.
Zolpidem (2) · Phenobarbital (1) · Phenytoin (1) · Carbamazepine (1) · Oxcarbazepine (1) · Valproic Acid (1) · Lamotrigine (1) · Topiramate (1)
Related medicines
As reviewed, each with the page that says it.
- One of Hypnotics and Sedatives source
Studies
Open first, then newest update. How each study uses zaleplon is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 9
- Zaleplon 10 mg Capsules Under Non-Fasting ConditionsCompletedPhase 1Teva Pharmaceuticals USANCT00829868Written as Zaleplon 10 mg Capsules
- Zaleplon 10mg Capsules Under Fasting ConditionsCompletedPhase 1Teva Pharmaceuticals USANCT00829998Written as Zaleplon 10 mg Capsules
- Zaleplon in HIV Patients With DepressionCompletedPhase 2University of PennsylvaniaNCT03489304Written as Zaleplon
- Pharmacovigilance in Gerontopsychiatric PatientsTerminatedPhase 3Hannover Medical SchoolNCT02374567Written as Zaleplon
- Bioequivalency Study of Zaleplon 10 mg Capsules Under Fed ConditionsCompletedNot applicableRoxane LaboratoriesNCT00694317Written as Zaleplon
- Bioequivalency Study of Zaleplon 10 mg Capsules Under Fasting ConditionsCompletedNot applicableRoxane LaboratoriesNCT00694187Written as Zaleplon
- Staccato Zaleplon Single Dose PharmacokineticsCompletedPhase 1Alexza Pharmaceuticals, Inc.NCT00620620Written as Inhaled Zaleplon 0.5 mg
- Hypnotic Medications and Memory: Effect of Drug Exposure During the NightCompletedPhase 4St. Luke's Hospital, Chesterfield, MissouriNCT01159652Written as zaleplon
- Study of Sleep-maintenance Activity of 3 Doses of SKP-1041CompletedPhase 2Somnus Therapeutics, Inc.NCT00878553Written as SKP-1041 (experimental formulation of zaleplon)
Codes
What other systems call zaleplon · ClinicalTrials.gg INT003772
- MeSH (NLM) C085665zaleplonConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) S62U433RMHZALEPLONConfirmed FDA, NLM, Wikidata
- RxNorm 74667Confirmed FDA, Wikidata
- Wikidata Q145052zaleplonConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C29551ZaleplonOne source FDA
- DrugBank DB00962One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C085665 | zaleplon | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | S62U433RMH | ZALEPLON | Confirmed FDA, NLM, Wikidata |
| RxNorm | 74667 | — | Confirmed FDA, Wikidata |
| Wikidata | Q145052 | zaleplon | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C29551 | Zaleplon | One source FDA |
| DrugBank | DB00962 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.